A novel aurone RNA CAG binder inhibits the huntingtin RNA-protein interaction.

Huntington's disease (HD) is a devastating, incurable condition whose pathophysiological mechanism relies on mutant RNA CAG repeat expansions. Aberrant recruitment of RNA-binding proteins by mutant CAG hairpins contributes to the progress of neurodegeneration. In this work, we identified a novel binder based on an aurone scaffold that reduces the level of binding of HTT mRNA to the MID1 protein . The obtained results introduce aurones as a novel platform for the design of functional ligands for disease-related RNA sequences.